Cite Filings / IMVT / 0001764013-26-000094

Feed Companies Filings Check

Sign in

ARS

Annual Report to Security Holders

Immunovant, Inc. Filed 2026-07-22 Acc 0001764013-26-000094

Documents 1

ARS Annual Report to Security Holders , imvt-20260331x10kfinal5x20.pdf

Around this filing

2026-07-24 4 Chief Technology Officer sold 2,857 shares at $38.69 ($110,537)
2026-07-24 4 Director sold 1,500 shares at $39.80 ($59,700)
2026-07-24 4 Chief Financial Officer sold 6,798 shares at $38.69 ($263,015)
2026-07-22 ARS Annual Report to Security Holders
2026-07-22 DEFA14A Proxy Materials
2026-07-22 DEF 14A Proxy Statement
2025-07-09 ARS Annual Report to Security Holders

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading imvt-20260331x10kfinal5x20.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…